Previous Close | 0.7327 |
Open | 0.7310 |
Bid | 0.7375 x 0 |
Ask | 0.7760 x 0 |
Day's Range | 0.7310 - 0.7625 |
52 Week Range | 0.6500 - 1.2190 |
Volume | |
Avg. Volume | 75,954 |
Market Cap | 592.789M |
Beta (5Y Monthly) | 0.87 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
As global markets navigate a turbulent landscape marked by lower stock performances amid busy earnings reports and mixed economic signals, small-cap stocks have demonstrated resilience compared to their larger counterparts. In this environment, identifying promising investment opportunities requires a keen eye for companies with strong fundamentals and the potential to thrive in sectors like high-growth tech, where innovation can drive significant returns.
Pharming Group (PHGUF) reports a 12% revenue increase in Q3 2024, driven by Ruconest and Joenja, while navigating operational losses and market expansion efforts.